World Journal of Pediatrics

, Volume 5, Issue 3, pp 177–181

Use of inhaled corticosteroids decreases hospital admissions for asthma in young children

  • Kaj Korhonen
  • Teija Dunder
  • Timo Klaukka
  • Tiina M. Reijonen
  • Matti Korppi
Original Article



An active use of inhaled corticosteroids for asthma has been associated with less asthma exacerbations and hospital admissions in children aged more than 2 years. The present study aimed to investigate hospital admission rates in young children from two populations in relation to the age-specific use of maintenance medication for asthma.


Annual data on children aged less than 24 months treated for asthma, including data on the use of maintenance medication based on the purchases of prescribed medications, and annual numbers of admissions to hospital and proportions of readmissions, were collected from 1995 to 1999 in two provinces of Finland. The inclusion criteria, three or more doctor-diagnosed wheezing episodes, were individually checked by the authors in each case. The mean number of children aged less than 24 months during the years of the study was 5490 in Kuopio and 9914 in Oulu area.


In the Kuopio area, during the years of the study, 16.5/1000 children aged less than 24 months were on maintenance medication for asthma, and 90% of them were receiving inhaled corticosteroids. In the Oulu area, the respective figures were 13.5/1000 (P<0.001) and 99%. The average admission rate was 7.9/1000 in the Kuopio area and 8.7/1000 in the Oulu area (P<0.05). The readmissions indicated the higher admission rates in the Oulu (40% of all admissions) than in the Kuopio (28%) area (P<0.01).


Active use of maintenance therapy by inhaled corticosteroids was associated with a decreased need of hospital treatment in young children <24 months old with asthma, mainly because of less readmissions.

Key words

asthma child hospitalization rate inhaled corticosteroids population-based study 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wennergren G, Kristjánsson S, Strannegård I-L. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol 1996;97:742–748.PubMedCrossRefGoogle Scholar
  2. 2.
    Morrison DS, McLoone P. Changing patterns of hospital admission for asthma, 1981–97. Thorax 2001;56:687–690.PubMedCrossRefGoogle Scholar
  3. 3.
    Wennergren G, Strannegård IL. Asthma hospitalizations continue to decrease in schoolchildren but hospitalization rates for wheezing illnesses remain high in young children. Acta Paediatr 2002;91:1239–1245.PubMedCrossRefGoogle Scholar
  4. 4.
    Säynäjäkangas O, Valmari P, Tuuponen T, Keistinen T. Trends in hospitalization for childhood asthma in Finland in 1996–2004. Acta Paediatr 2007;96:919–923.PubMedCrossRefGoogle Scholar
  5. 5.
    Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled corticosteroids and the risk of hospitalization for asthma. JAMA 1997;277:887–891.PubMedCrossRefGoogle Scholar
  6. 6.
    Bisgaard H, Moller H. Changes in risk of hospital readmission among asthmatic children in Denmark, 1978–93. BMJ 1999;319:229–230.PubMedGoogle Scholar
  7. 7.
    Minkovitz C, Andrews J, Serwint J. Rehospitalization of children with asthma. Arch Pediatr Adolesc Med 1999;153:727–730.PubMedGoogle Scholar
  8. 8.
    Wever-Hess J, Hermans J, Kouwenberger JM, Duiverman EJ, Wever AM. Hospital admissions and readmissions for asthma in the age group 0–4 years. Pediatr Pulmonol 2001;31:30–36.PubMedCrossRefGoogle Scholar
  9. 9.
    Korhonen K, Dunder T, Klaukka T, Reijonen TM, Issakoff K, Kiviharju M, et al. Do inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children. Acta Paediatr 2004;93:1612–1618.PubMedCrossRefGoogle Scholar
  10. 10.
    Gardner MJ, Altman DG. Confidence intervals for standardised ratios and rates. In: Gardner MJ, Altman DG, eds. Statistics with Confidence. London: BMJ, 1989: 59–60.Google Scholar
  11. 11.
    Bisgaard H, Szefler S. Understanding mild persistent asthma in children: the next frontier. J Allergy Clin Immunol 2005;115:708–713.PubMedCrossRefGoogle Scholar
  12. 12.
    Wickman M, Farahmand BY, Persson PG, Pershagen G. Hospitalization for lower respiratory disease during 20 yrs among under 5 yr children in Stockholm county: a population based survey. Eur Respir J 1998;11:366–370.PubMedCrossRefGoogle Scholar
  13. 13.
    van Woensel JB, van Aalderen WM, Kneyber MC, Heijnen ML, Kimpen JL. Bronchiolitis hospitalizations in the Netherlands from 1991 to 1999. Arch Dis Child 2002;86:370–371.PubMedCrossRefGoogle Scholar
  14. 14.
    Björ O, Bråbäck L. A retrospective population based trend analysis on hospital admissions for lower respiratory illness among Swedish children from 1987 to 2000. BMC Public Health 2003;3:22–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998–2005.PubMedCrossRefGoogle Scholar
  16. 16.
    Bisgaard H; Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379–383.PubMedCrossRefGoogle Scholar
  17. 17.
    Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2 to 5 years old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315–322.PubMedCrossRefGoogle Scholar
  18. 18.
    Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, et al. Diagnosis and treatment of asthma in children: a PRACTALL consensus report. Allergy 2008;63:5–34.PubMedCrossRefGoogle Scholar
  19. 19.
    Saglani S, Malmström K, Pelkonen AS, Malmberg LP, Lindahl H, Kajosaari M, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722–727.PubMedCrossRefGoogle Scholar
  20. 20.
    Reijonen T, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998;26:113–119.PubMedCrossRefGoogle Scholar
  21. 21.
    Hofhuis W, van der Wiel EC, Nieuwhof EM, Hop WC, Affourtit MJ, Smit FJ, et al. Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Am J Respir Crit Care Med 2005;171:328–333.PubMedCrossRefGoogle Scholar
  22. 22.
    Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985–1997.PubMedCrossRefGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag GmbH 2009

Authors and Affiliations

  • Kaj Korhonen
    • 1
  • Teija Dunder
    • 2
  • Timo Klaukka
    • 3
  • Tiina M. Reijonen
    • 1
  • Matti Korppi
    • 4
    • 5
  1. 1.Department of PediatricsKuopio University HospitalKuopioFinland
  2. 2.Department of PediatricsOulu University HospitalOuluFinland
  3. 3.Social Insurance InstitutionHelsinkiFinland
  4. 4.Pediatric Research CenterTampere University and University HospitalTampereFinland
  5. 5.Pediatric Research CenterTampere University and University HospitalTampereFinland

Personalised recommendations